Next Generation Molecular Assay Market

Next Generation Molecular Assay Market Overview

The global next generation molecular assay market was valued at around USD 4,976.30 Million at the end of 2021. The market is projected to register a 5.16% CAGR and top a valuation of USD 8,654.92 Million by 2032.

The market for next generation molecular assay market is anticipated to propel due to factors such technological development, an ageing population, and rising demand for genetic testing.

Worldwide, there has been a growth in the use of next-generation molecular assays due to a number of advantages over traditional testing, including the ability to do multiple assays, reliable results, and faster processing. High degree of precision has been achieved by next generation molecular test.

The use of next-generation molecular assays in therapeutic medication monitoring and drug prescription selection with the aim of avoiding toxicity and other adverse effects has been made possible by benefits including fewer mistakes and improved detection and quantification.

Attributes	Details
Next Generation Molecular Assay Market Value in 2021	USD 4,976.30 Million
Next Generation Molecular Assay Market Value in 2032	USD 8,654.92 Million
Next Generation Molecular Assay Market CAGR (2022 to 2032)	5.16%

What are the Major Drivers Boosting the Demand for Next Generation Molecular Assay Market?

A significant factor driving the global market for next-generation molecular assays is improved reimbursement regulations. An increasing trend in the global market for next generation molecular assays, including genomics and proteomics, is likely to fuel the industry's expansion. These assays were created as a result of improvements in in-vitro detection techniques.

The ability to identify novel virus variants, genomic alterations in pathogens, and other advancements related to next generation molecular assays are some of the reasons supporting the growth of the next generation molecular assay market.

Which Region Shows Strong Growth Potential in the Next Generation Molecular Assay Market?

The Next Generation Molecular Assay Market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

North America is anticipated to have a dominating position in the global next generation molecular assay market as a result of rising R&D spending, advantageous reimbursement scenarios, and a growing emphasis on creating cutting-edge technologies.

Moreover, Asia Pacific is expected to have a significant growth potential for the next generation molecular assay market during the forecast period due to the rising number of R&D facilities and rising government spending on healthcare.

Who are the Key Manufacturers in the Next Generation Molecular Assay Market?

Thermo Fisher Scientific Inc, Invivoscribe, Myriad Genetics Inc, Becton, Dickinson and Company, Molecular Devices, LLC, Luminex Corporation, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Tecan Trading AG, Agilent Technologies Inc, and Danaher Corporation.

Scope of Report

Report Attributes	Details
Growth Rate	CAGR of 5.16% 2022 to 2032
Base Year for Estimation	2021
Historical Data	2012 to 2021
Forecast Period	2022 to 2032
Qualitative Units	Revenue in USD Million, Volume in Units, and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered	Test Type, Technique, End-User, Region
Region Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa
Key Countries Profiled	USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Spain, Italy, Russia, BENELUX, China, Japan, South Korea, India, Malaysia, Thailand, Indonesia, Australia, New Zealand, GCC Countries, South Africa, North Africa, Turkey
Key Players	Thermo Fisher Scientific Inc; Invivoscribe; Myriad Genetics Inc; Becton, Dickinson and Company; Molecular Devices, LLC; Luminex Corporation; Siemens Healthcare GmbH; F. Hoffmann-La Roche Ltd; Tecan Trading AG; Agilent Technologies Inc; Danaher Corporation
Customization	Available Upon Request

Table of Content

• 1. Executive Summary
• 2. Industry Introduction, including Taxonomy and Market Definition
• 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
• 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
• 5. Pricing Analysis
• 6. Global Market Analysis and Forecast
  • 6.1. By Test Type
  • 6.2. By Technique
  • 6.3. By End-User
• 7. Global Market Analysis and Forecast, By Test Type
  • 7.1. Virus testing
  • 7.2. HPV testing
  • 7.3. HIV testing
  • 7.4. Influenza testing
  • 7.5. HCV testing
  • 7.6. Others
  • 7.7. Blood Testing
  • 7.8. Genetic Testing
  • 7.9. Oncological Testing
  • 7.10. STD Testing
• 8. Global Market Analysis and Forecast, By Technique
  • 8.1. Polymerase chain reaction (PCR)
  • 8.2. Enzyme-Linked Immuno-Sorbent Assay (ELISA)
  • 8.3. Microarrays
  • 8.4. Gene expression profiling assays
  • 8.5. Others
• 9. Global Market Analysis and Forecast, By End-User
  • 9.1. Hospitals
  • 9.2. Academic & Research Centers
  • 9.3. Biopharmaceutical Companies
  • 9.4. Others
• 10. Global Market Analysis and Forecast, By Region
  • 10.1. North America
  • 10.2. Latin America
  • 10.3. Europe
  • 10.4. East Asia
  • 10.5. South Asia
  • 10.6. Oceania
  • 10.7. The Middle East and Africa (MEA)
• 11. North America Sales Analysis and Forecast, by Key Segments and Countries
• 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
• 13. Europe Sales Analysis and Forecast, by Key Segments and Countries
• 14. East Asia Sales Analysis and Forecast, by Key Segments and Countries
• 15. South Asia Sales Analysis and Forecast, by Key Segments and Countries
• 16. Oceania Sales Analysis and Forecast, by Key Segments and Countries
• 17. The Middle East and Africa (MEA) Sales Analysis and Forecast, by Key Segments and Countries
• 18. Sales Forecast by Test Type, Technique, and End-User for 30 Countries
• 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
• 20. Company Profile
  • 20.1. Thermo Fisher Scientific Inc
  • 20.2. Invivoscribe
  • 20.3. Myriad Genetics Inc
  • 20.4. Becton, Dickinson and Company
  • 20.5. Molecular Devices, LLC
  • 20.6. Luminex Corporation
  • 20.7. Siemens Healthcare GmbH
  • 20.8. F. Hoffmann-La Roche Ltd
  • 20.9. Tecan Trading AG
  • 20.10. Agilent Technologies Inc
  • 20.11. Danaher Corporation